We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use an N-of-1 study to evaluate your digital health product.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
We help people, businesses and the UK economy by promoting competitive markets and tackling unfair behaviour. CMA is a non-ministerial department.
Guidance for the veterinary pharmaceutical industry on the production and submission of the Summary of Product Characteristics (SPCs) and product literature mock-ups.
Guidance and calculators for working out nutrient budgets for proposed developments on 27 specific habitats sites.
Using metadata to make it easier to catalogue, validate, reuse and share your data.
How to use a randomised controlled trial to evaluate your digital health product.
All essential shared data assets (ESDA) must be assessed for data quality issues, made findable and be available through APIs.
Information for schools about the standard setting process for key stage 1 national curriculum tests in 2016.
Development of a standard approach for AI and autonomy in networked multi-sensor systems in security and defence.
Learn how to check if your website or mobile app is accessible.
How to use a case-control study to evaluate your digital health product.
The Data Standards Authority has published standards and guidance on how to improve data sharing across government.
Comply with good pharmacovigilance practice and prepare for an inspection.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Information for schools about the standard setting process for key stage 2 national curriculum tests.
Standardisation explained.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
This is a list of all the opinions the RPC issued in 2021 on HM Treasury measures.
Find out about gaining approval for a fair partial exemption special method if you deal with partial exemption for insurers.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.